Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 24 shown

Commercialized according to BDPM

SYNAGIS 100 mg/ml, solution for injection

Active ingredients: Palivizumab

Original BDPM details in French

Official name: SYNAGIS 100 mg/ml, solution injectable
Active ingredients: PALIVIZUMAB
Package description: 1 flacon(s) en verre de 1 ml

CIS 67810869CIP7 3007232CIP13 3400930072325

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

SYNAGIS 50 mg/0.5 ml, solution for injection

Active ingredients: Palivizumab

Original BDPM details in French

Official name: SYNAGIS 50 mg/0,5 ml, solution injectable
Active ingredients: PALIVIZUMAB
Package description: 1 flacon(s) en verre de 0,5 ml

CIS 68932534CIP7 3007231CIP13 3400930072318

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

CIMZIA 200 mg, solution for injection in a pre-filled syringe

Active ingredients: CERTOLIZUMAB PÉGOL

Original BDPM details in French

Official name: CIMZIA 200 mg solution injectable en seringue préremplie
Active ingredients: CERTOLIZUMAB PÉGOL
Package description: 2 seringue(s) préremplie(s) en verre de 1 ml avec 2 tampon(s) alcoolisé(s)

CIS 66661714CIP7 3973200CIP13 3400939732008

View details

Estimated price€1,162.70No current ANSM shortage notice is included

Commercialized according to BDPMANSM notice

CIMZIA 200 mg, solution for injection in a pre-filled pen

Active ingredients: CERTOLIZUMAB PÉGOL

Original BDPM details in French

Official name: CIMZIA 200 mg, solution injectable en stylo prérempli
Active ingredients: CERTOLIZUMAB PÉGOL
Package description: 2 stylos préremplis en verre Autoclicks de 1 ml avec 2 tampon(s) alcoolisé(s)

CIS 64386835CIP7 3007628CIP13 3400930076286

View details

Estimated price€1,162.70Supply disruption

Commercialized according to BDPM

ENSPRYNG 120 mg, solution for injection in a pre-filled syringe

Active ingredients: Satralizumab

Original BDPM details in French

Official name: ENSPRYNG 120 mg, solution injectable en seringue préremplie
Active ingredients: SATRALIZUMAB
Package description: 1 seringue(s) préremplie(s) polymère de 1 ml

CIS 69326436CIP7 3023443CIP13 3400930234433

View details

Estimated price€15,122.68No current ANSM shortage notice is included

Commercialized according to BDPM

FASENRA 30 mg, solution for injection in a pre-filled syringe

Active ingredients: Benralizumab

Original BDPM details in French

Official name: FASENRA 30 mg, solution injectable en seringue préremplie
Active ingredients: BENRALIZUMAB
Package description: 1 seringue préremplie en verre de 1 ml avec une aiguille et un protège -aiguille rigide et un bouchon-piston

CIS 63562134CIP7 3013294CIP13 3400930132944

View details

Estimated price€3,994.88No current ANSM shortage notice is included

Commercialized according to BDPM

FASENRA 30 mg, solution for injection in a pre-filled pen

Active ingredients: Benralizumab

Original BDPM details in French

Official name: FASENRA 30 mg, solution injectable en stylo prérempli
Active ingredients: BENRALIZUMAB
Package description: 1 stylo prérempli en verre de 1 ml avec une aiguille et un protège -aiguille rigide et un bouchon-piston

CIS 63094493CIP7 3018783CIP13 3400930187838

View details

Estimated price€3,994.88No current ANSM shortage notice is included

Commercialized according to BDPM

OMLYCLO 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: OMLYCLO 150 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre de 1 mL

CIS 69603381CIP7 3029436CIP13 3400930294369

View details

Estimated price€312.48No current ANSM shortage notice is included

Commercialized according to BDPM

OMLYCLO 150 mg, solution for injection in a pre-filled pen

Active ingredients: Omalizumab

Original BDPM details in French

Official name: OMLYCLO 150 mg, solution injectable en stylo prérempli
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre dans stylo pré-rempli de 1 ml

CIS 62401391CIP7 3031696CIP13 3400930316962

View details

Estimated price€312.48No current ANSM shortage notice is included

Commercialized according to BDPM

OMLYCLO 300 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: OMLYCLO 300 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre de 2 mL

CIS 65804497CIP7 3032872CIP13 3400930328729

View details

Estimated price€619.60No current ANSM shortage notice is included

Commercialized according to BDPM

OMLYCLO 300 mg, solution for injection in a pre-filled pen

Active ingredients: Omalizumab

Original BDPM details in French

Official name: OMLYCLO 300 mg, solution injectable en stylo prérempli
Active ingredients: OMALIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre dans stylo pré-rempli de 2 ml

CIS 62515797CIP7 3033933CIP13 3400930339336

View details

Estimated price€619.60No current ANSM shortage notice is included

Commercialized according to BDPM

OMLYCLO 75 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: OMLYCLO 75 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre de 0,5 mL

CIS 66107946CIP7 3029434CIP13 3400930294345

View details

Estimated price€158.30No current ANSM shortage notice is included

Commercialized according to BDPM

OMLYCLO 75 mg, solution for injection in a pre-filled pen

Active ingredients: Omalizumab

Original BDPM details in French

Official name: OMLYCLO 75 mg, solution injectable en stylo prérempli
Active ingredients: OMALIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre dans stylo pré-rempli de 0,5 ml

CIS 60909042CIP7 3031695CIP13 3400930316955

View details

Estimated price€158.30No current ANSM shortage notice is included

Commercialized according to BDPM

TYRUKO 300 mg, concentrate for solution for infusion

Active ingredients: Natalizumab

Original BDPM details in French

Official name: TYRUKO 300 mg, solution à diluer pour perfusion
Active ingredients: NATALIZUMAB
Package description: 1 flacon en verre de 15 mL

CIS 60779570CIP7 5509727CIP13 3400955097273

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TYSABRI 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Natalizumab

Original BDPM details in French

Official name: TYSABRI 150 mg, solution injectable en seringue préremplie
Active ingredients: NATALIZUMAB
Package description: 2 seringue(s) préremplie(s) en verre de 1 ml

CIS 61863110CIP7 3031855CIP13 3400930318553

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TYSABRI 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Natalizumab

Original BDPM details in French

Official name: TYSABRI 150 mg, solution injectable en seringue préremplie
Active ingredients: NATALIZUMAB
Package description: 2 seringue(s) préremplie(s) en verre de 1 ml ( abrogée le 14/05/2025)

CIS 61863110CIP7 5508038CIP13 3400955080381

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TYSABRI 300 mg, concentrate for solution for infusion

Active ingredients: Natalizumab

Original BDPM details in French

Official name: TYSABRI 300 mg, solution à diluer pour perfusion
Active ingredients: NATALIZUMAB
Package description: 1 flacon(s) en verre de 15 ml

CIS 68722564CIP7 5699677CIP13 3400956996773

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

XOLAIR 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: XOLAIR 150 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 1 ml avec une aiguille sertie de calibre 27 gauge dans une plaquette thermoformée

CIS 61971520CIP7 3028113CIP13 3400930281130

View details

Estimated price€414.98No current ANSM shortage notice is included

Commercialized according to BDPM

XOLAIR 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: XOLAIR 150 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s) et avec protège-aiguille

CIS 61971520CIP7 3921249CIP13 3400939212494

View details

Estimated price€414.98No current ANSM shortage notice is included

Commercialized according to BDPM

XOLAIR 150 mg, solution for injection in a pre-filled pen

Active ingredients: Omalizumab

Original BDPM details in French

Official name: XOLAIR 150 mg, solution injectable en stylo prérempli
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre de 1 ml dans stylo pré-rempli

CIS 65161930CIP7 3028116CIP13 3400930281161

View details

Estimated price€414.98No current ANSM shortage notice is included

Commercialized according to BDPM

XOLAIR 300 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: XOLAIR 300 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre de 2 mL avec une aiguille sertie de calibre 27 gauge dans une plaquette thermoformée

CIS 61771263CIP7 3028115CIP13 3400930281154

View details

Estimated price€824.30No current ANSM shortage notice is included

Commercialized according to BDPM

XOLAIR 300 mg, solution for injection in a pre-filled pen

Active ingredients: Omalizumab

Original BDPM details in French

Official name: XOLAIR 300 mg, solution injectable en stylo prérempli
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre de 2 mL dans stylo pré-rempli

CIS 65134723CIP7 3028114CIP13 3400930281147

View details

Estimated price€824.30No current ANSM shortage notice is included

Commercialized according to BDPM

XOLAIR 75 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: XOLAIR 75 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 0,5 ml une aiguille sertie de calibre 27 gauge dans une plaquette thermoformée

CIS 62877141CIP7 3028110CIP13 3400930281109

View details

Estimated price€209.72No current ANSM shortage notice is included

Commercialized according to BDPM

XOLAIR 75 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: XOLAIR 75 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s) et avec protège-aiguille

CIS 62877141CIP7 3921226CIP13 3400939212265

View details

Estimated price€209.72No current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.